High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Table 3

Multivariate analysis of prognostic factors independently associated with overall survival (OS) in patients with resectable pancreatic ductal adenocarcinoma.

Characteristics	Hazard ratio	95% CI	value
CA19-9 (U/mL)	0.298	0.116-0.769	0.012
<37
≥37
Histological differentiation	2.080	0.947-4.572	0.068
Well/moderate
Poor
Expression of JAK2	0.476	0.230-0.988	0.046
High
Low